We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$947M
AUM Growth
+$42.3M
Cap. Flow
-$10.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
37.5%
Holding
265
New
13
Increased
83
Reduced
137
Closed
13

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$4.11M
2
POOL icon
Pool Corp
POOL
+$4M
3
EL icon
Estee Lauder
EL
+$3.62M
4
CRM icon
Salesforce
CRM
+$2.95M
5
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$2.51M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.48M
2
DHI icon
D.R. Horton
DHI
+$4.76M
3
CSCO icon
Cisco
CSCO
+$4.46M
4
STZ icon
Constellation Brands
STZ
+$4.2M
5
DGX icon
Quest Diagnostics
DGX
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 21.18%
2 Healthcare 10.11%
3 Financials 8.69%
4 Consumer Discretionary 6.97%
5 Industrials 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
26
S&P Global
SPGI
$133B
$9.09M 0.96%
22,679
+961
+4% +$351K
ABT icon
27
Abbott
ABT
$175B
$8.17M 0.86%
74,921
+6,592
+10% +$703K
ZTS icon
28
Zoetis
ZTS
$32.1B
$8.13M 0.86%
47,217
+1,697
+4% +$293K
HON icon
29
Honeywell
HON
$71.3B
$7.77M 0.82%
39,712
-694
-2% -$129K
REGN icon
30
Regeneron Pharmaceuticals
REGN
$70.9B
$7.51M 0.79%
10,446
-921
-8% -$710K
SWKS icon
31
Skyworks Solutions
SWKS
$8.93B
$7.42M 0.78%
66,996
+4,123
+7% +$435K
NKE icon
32
Nike
NKE
$64.9B
$7.2M 0.76%
65,267
+1,939
+3% +$227K
CRM icon
33
Salesforce
CRM
$140B
$6.77M 0.72%
32,042
+14,470
+82% +$2.95M
TEL icon
34
TE Connectivity
TEL
$59.3B
$6.45M 0.68%
45,985
+2,676
+6% +$338K
ACN icon
35
Accenture
ACN
$87.9B
$6.18M 0.65%
20,024
+1,204
+6% +$350K
MDLZ icon
36
Mondelez International
MDLZ
$78.3B
$6.17M 0.65%
84,588
-612
-0.7% -$45.2K
DIS icon
37
Walt Disney
DIS
$170B
$6.07M 0.64%
67,990
+116
+0.2% +$11K
AXP icon
38
American Express
AXP
$242B
$5.93M 0.63%
34,041
+1,248
+4% +$201K
MKSI icon
39
MKS Inc
MKSI
$21.9B
$5.71M 0.6%
52,862
+6,695
+15% +$613K
FDX icon
40
FedEx
FDX
$74.7B
$5.64M 0.6%
22,761
-56
-0.2% -$12.8K
VTWO icon
41
Vanguard Russell 2000 ETF
VTWO
$17.5B
$5.5M 0.58%
72,691
+10,464
+17% +$754K
MRK icon
42
Merck
MRK
$315B
$5.29M 0.56%
45,864
+20
+0% +$2.27K
LMT icon
43
Lockheed Martin
LMT
$117B
$5.17M 0.55%
11,226
-769
-6% -$357K
VTI icon
44
Vanguard Total Stock Market ETF
VTI
$658B
$5.09M 0.54%
23,112
+834
+4% +$174K
AMGN icon
45
Amgen
AMGN
$198B
$5.04M 0.53%
22,691
-23,625
-51% -$5.48M
PEP icon
46
PepsiCo
PEP
$187B
$4.96M 0.52%
26,763
-1,089
-4% -$203K
SSNC icon
47
SS&C Technologies
SSNC
$16.8B
$4.87M 0.51%
80,424
+5,481
+7% +$312K
LHX icon
48
L3Harris
LHX
$52.5B
$4.74M 0.5%
24,202
+1,303
+6% +$249K
VTV icon
49
Vanguard Value ETF
VTV
$186B
$4.61M 0.49%
32,418
+578
+2% +$80.3K
ECL icon
50
Ecolab
ECL
$76.8B
$4.52M 0.48%
24,211
-425
-2% -$73.1K
1
2
3 4 5

Similar funds

PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return

Girard Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Girard Partners held 265 positions worth $947M, up 4.7% from $904M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Girard Partners's Q2 2023 filing shows 13 new, 83 increased, 137 reduced and 13 closed positions. Its largest new stake was Charles River Laboratories: 20,680 shares worth $4.35M. The largest sale was Amgen, an estimated $5.48M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Girard Partners's largest Q2 2023 buy was Charles River Laboratories: 20,680 shares worth $4.35M.
  • Girard Partners added most to Estee Lauder in Q2 2023, an estimated $3.62M increase.
  • Girard Partners's biggest Q2 2023 reduction was Amgen, cutting an estimated $5.48M.
  • Girard Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2023, selling an estimated $608K.
  • Girard Partners's ten largest holdings make up 37% of its $947M portfolio in Q2 2023.
  • Girard Partners opened 13 new positions and closed 13 in Q2 2023.
  • Girard Partners's portfolio value rose 4.7% quarter-over-quarter to $947M.

Based on Girard Partners's 13F filing for Q2 2023, filed 15 Aug 2023.